Patents Assigned to T-CELL TECHNOLOGIES, INC.
  • Publication number: 20140127805
    Abstract: The invention is intended to further improve the operability, economic efficiency and safety in the preparation of antigen-specific CTLs. The invention provides a preparation kit used for a method for preparing antigen-specific cytotoxic T lymphocytes, the method comprising: a first step for inducing antigen-specific cytotoxic T lymphocytes, wherein the components of the first step include a culture medium contained in an injection vessel, a hermetically scaled culture vessel, and the like; a second step for preparing an activated T cell for antigen presentation, wherein the components of the second step include a culture medium contained in an injection vessel, a hermetically sealed culture vessel, and the like.; and a third step for proliferating antigen-specific cytotoxic T lymphocytes, wherein the components of the third step include a culture medium contained in an injection vessel, a hermetically sealed separation vessel, a hermetically sealed culture vessel, and the like.
    Type: Application
    Filed: December 20, 2013
    Publication date: May 8, 2014
    Applicants: T-CELL TECHNOLOGIES, INC., NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY, MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.
    Inventors: Susumu SUZUKI, Seiji KOJIMA, Tomoki NAOE